Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Guidewire Software Inc. Common Stock (GWRE) vs Medline Inc. Class A Common Stock (MDLN) Price & Performance

Guidewire Software Inc. Common StockTrade
Medline Inc. Class A Common StockTrade

Price performance (Past 24H)

Key statistics

Guidewire Software Inc. Common Stock vs Medline Inc. Class A Common Stock — how do they compare? Guidewire Software Inc. Common Stock trades at $163.81 (market cap $13.52B), while Medline Inc. Class A Common Stock trades at $36 (market cap $31.54B). The key difference: Medline Inc. Class A Common Stock is far larger — about 2.3× Guidewire Software Inc. Common Stock's market cap, and Guidewire Software Inc. Common Stock is trading nearer its 52-week high, Medline Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Guidewire Software Inc. Common Stock for 0 Days and Medline Inc. Class A Common Stock for 6 Days on average.

GWREMDLN
Market Cap
$13.52B$31.54B
Volume
897,7084,637,232
Sector
TechnologyHealth
52-Week High
$254.23$49.99
52-Week Low
$102.69$31.64
Typical Hold Time
0 Days6 Days
Enterprise Value
$13.48B$41.50B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Guidewire Software Inc. Common Stock

No Aura AI signal available yet.

Medline Inc. Class A Common Stock

Medline (MDLN) trades at $35.70, down 0.17% with a bullish technical outlook despite recent volatility. The company shows strong revenue growth with $28.43B in 2025 and improved earnings beats in Q1-Q2 2026. However, multiple securities fraud investigations related to product quality issues and a 13% stock drop in October 2026 create significant headwinds. Analyst consensus remains strongly bullish with 88% buy ratings and a $44.11 price target, representing 23.6% upside potential from current levels.

MDLN presents a high-risk, high-reward opportunity with strong fundamentals offset by legal uncertainties. The stock's valuation appears reasonable with P/E of 44.66 and P/S of 1.05, while technical indicators suggest near-term support at $35. Key risks include ongoing fraud investigations and potential legal liabilities that could impact future performance despite positive earnings momentum.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GWRE
100% Buy0% Sell
Avg holding period · 0 Days
MDLN

No sentiment data available yet.

Top news

Latest headlines on both assets

About Guidewire Software Inc. Common Stock

Guidewire Software Inc. develops InsuranceSuite Cloud, a software platform used by property and casualty insurers for policy administration, billing, and claims processing.

Read more on GWRE →

About Medline Inc. Class A Common Stock

Medline provides medical-surgical products and supply-chain solutions for healthcare providers. Its portfolio and distribution network serve hospitals, clinics, long-term care facilities, and other care settings.

Read more on MDLN →